Inogen (INGN) Operating Income Growth (1y) (2014 - 2026)
Inogen (INGN) Operating Income Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | Inogen | 151.86 Mn | 46.32 Mn | 43.27 Mn | 16.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.85% |
| Mar 31, 2026 | -21.94% |
| Dec 31, 2025 | 18.27% |
| Sep 30, 2025 | 8.68% |
| Jun 30, 2025 | 13.24% |
| Mar 31, 2025 | 52.96% |
| Dec 31, 2024 | 60.71% |
| Sep 30, 2024 | 83.32% |
| Jun 30, 2024 | 39.97% |
| Mar 31, 2024 | 25.74% |
| Dec 31, 2023 | 50.45% |
| Sep 30, 2023 | -353.95% |
| Jun 30, 2023 | -309.18% |
| Mar 31, 2023 | -61.31% |
| Dec 31, 2022 | -776.50% |
| Sep 30, 2022 | -261.47% |
| Jun 30, 2022 | -124.64% |
| Mar 31, 2022 | -537.24% |
| Dec 31, 2021 | -20.84% |
| Sep 30, 2021 | 423.06% |